Skip to content
Latest News
Tesla Decline Provides a Buying Opportunity, Says Analyst

Despite Tesla’s (NASDAQ: TSLA) share price decline Morgan Stanley’s Adam Jonas believes it provides investors with a buying opportunity.

Sam Boughedda
Palantir Shorts to Make Money, Says Wolfe Research Analyst

Palantir (NYSE: PLTR) shares are down more than 64% in 2022, but Wolfe Research analyst Alex Zukin believes there can be money made on the short side.

Sam Boughedda
Former FTX Boss Extradited to US, as Former Colleagues Plead Guilty

Sam Bankman-Fried has been extradited to the United States, as two of his former colleagues have pleaded guilty to their roles in the collapse of the huge cryptocurrency exchange, FTX. This comes as FTX is trying to claw back

Steve Miley
Alba Mineral Shares Rallied 20% on High-Grade Assay Results

The Alba Mineral Resources plc (LON: ALBA) share price rallied 20% after its portfolio company GreenRoc Mining Plc (LON: GROC) released the complete set of phase II drilling assay results from its flagship Amitsoq Graphite Pr

Simon Mugo
Seeing Machines Wins Additional $32m FOVIO Driver Monitoring Contract

Seeing Machines Limited (LON: SEE) said Thursday that a large European-based global automotive (OEM) customer has given the company an additional programme to deliver its FOVIO Driver and Occupant Monitoring System (DMS/OMS).

Sam Boughedda
Immupharma Shares Surged 18% as Executives Forfeit Their Pay

The ImmuPharma PLC (LON: IMM) share price surged 18.3% after releasing its end-of-year update, in which the management team acknowledged that the company had not met the targets set at the beginning of 2022.

Simon Mugo
WANdisco Shares Continue Rise Following $12.7m Data Migration Deal With European Automotive Firm

WANdisco plc (LON: WAND) continued its recent rally Thursday, opening higher after the company said it has signed an initial agreement worth $12.7m with a global European-based automotive manufacturer.

Sam Boughedda
OKYO Pharma Shares Jumps After IND Receives FDA Clearance For Phase 2 Study

OKYO Pharma's (LON: OKYO) shares jumped 20% in early Thursday trading, hitting 2.7p per share after the company announced its Investigational New Drug (IND) application has received clearance from the US Food and Drug Adminis

Sam Boughedda
USDCAD Price: Canadian Dollar Rangebound Despite Upbeat CPI

The USDCAD currency pair traded sideways during the American session despite releasing upbeat Canadian inflation data early in the session. The headline CPI print rose 0.1% in November, beating analysts' estimates of zero cha

Simon Mugo
Venus Concept (VERO) Stock Rose 114% on 501k FDA Clearance

The Venus Concept Inc (NASDAQ: VERO) stock price surged 114.28% after receiving a 510(k) clearance from the U.S. Food and Drug Administration (“FDA”) to market its AI.ME next-generation robotic technology for fractional skin

Simon Mugo
Cineworld Shares Fell After AMC Abandoned Acquisition Talks

The Cineworld Group plc (LON: CINE) share price fell 18.4% after AMC Entertainment pulled out of talks to acquire some of the company’s assets in a deal funded by the issuance of APEs and debt financing from a group of lender

Simon Mugo
ADC Therapeutics Jumps On EC Marketing Authorisation For ZYNLONTA

ADC Therapeutics' (NYSE: ADCT) share price has risen more than 20% in early Wednesday trading after it announced that the European Commission (EC) has granted conditional marketing authorisation for ZYNLONTA.

Sam Boughedda
Centrica Shares Have Risen 44.8% Since October. What’s Next?

The Centrica PLC (LON: CNA) share price has rallied 44.8% to its current price after bottoming in October. The company’s share price has risen in tandem with rising gas prices, but the question on investors' minds is, will th

Simon Mugo
Oppenheimer Positive On Netflix Despite Reported Ad-Tier Execution Issues

Netflix NASDAQ: NFLX) shares are down by more than 50% in 2022, and recent reports have stated that the company is having issues with the execution of its ad-supported tier, but one analyst is still positive about its outlook

Sam Boughedda
Bunzl Expects To Deliver ‘Very Strong Growth’

Bunzl (LON: BNZL) shares opened Wednesday's session higher after releasing a trading update for the year ending December 31,2022, stating it expects to deliver "very strong growth" over the year.

Sam Boughedda
Nike Share Price Targets Raised Following Earnings Beat

Nike (NYSE: NKE) shares rose slightly in Tuesday's regular session, but the stock jumped in extended trading and premarket Wednesday after it reported its fiscal second quarter results.

Sam Boughedda
Taylor Wimpey Shares Are Up 24% Since October. What’s Next?

The Taylor Wimpey plc (LON: TW) share price has risen 24.1% since bottoming in October, and many are wondering whether the recent rally can extend into next year. As a homebuilder, Taylor Wimpey faces an uncertain future as w

Simon Mugo
Sam Bankman-Fried Agrees to Extradition; Uniswap Crypto Development; Binance Red Flags

Sam Bankman-Fried agrees to be extradited, according to the BBC, Users of the decentralized exchange Uniswap, will allow users to buy cryptocurrency using debit and credit cards, and also be able to use bank transfers to purc

Steve Miley
Oriole Resources Shares Fall After IAMGOLD Agrees to Sell Senala Option Agreement

Oriole Resources (LON: ORR) shares fell Wednesday after the company reported an update on its Senala Gold Project in Senegal. The AIM-quo

Sam Boughedda
Scotgold Shares Plunged 14% As FY22 Losses Double to A$10.8m

The Scotgold Resources Ltd (LON: SGZ) share price plunged 14.4% after releasing its annual results for the year ending 30 June 2022. The company generated total revenues of A$17.8 million in 2022, a significant improvement fr

Simon Mugo
Analysis Stocks Markets Strategies